Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

PFIZER vs MERCK LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More


Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More


Current Valuations

P/E (TTM) x 32.3 45.1 71.7% View Chart
P/BV x 5.1 6.6 77.7% View Chart
Dividend Yield % 0.7 0.5 129.2%  


5-Yr Chart
Click to enlarge
High Rs2,3651,358 174.2%   
Low Rs1,625933 174.2%   
Sales per share (Unadj.) Rs430.3665.0 64.7%  
Earnings per share (Unadj.) Rs78.756.6 139.1%  
Cash flow per share (Unadj.) Rs93.272.5 128.6%  
Dividends per share (Unadj.) Rs20.0015.00 133.3%  
Dividend yield (eoy) %1.01.3 76.5%  
Book value per share (Unadj.) Rs586.5441.7 132.8%  
Shares outstanding (eoy) m45.7516.60 275.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.61.7 269.2%   
Avg P/E ratio x25.320.2 125.2%  
P/CF ratio (eoy) x21.415.8 135.5%  
Price / Book Value ratio x3.42.6 131.2%  
Dividend payout %25.426.5 95.8%   
Avg Mkt Cap Rs m91,27119,011 480.1%   
No. of employees `0002.61.5 170.3%   
Total wages/salary Rs m3,1431,696 185.3%   
Avg. sales/employee Rs Th7,484.87,150.0 104.7%   
Avg. wages/employee Rs Th1,195.01,098.7 108.8%   
Avg. net profit/employee Rs Th1,369.1608.2 225.1%   
Net Sales Rs m19,68511,040 178.3%  
Other income Rs m1,143240 476.8%   
Total revenues Rs m20,82811,279 184.7%   
Gross profit Rs m5,0031,376 363.5%  
Depreciation Rs m663264 250.9%   
Interest Rs m40-   
Profit before tax Rs m5,4791,352 405.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0170 0.0%   
Tax Rs m1,878583 322.3%   
Profit after tax Rs m3,601939 383.4%  
Gross profit margin %25.412.5 203.9%  
Effective tax rate %34.343.1 79.5%   
Net profit margin %18.38.5 215.0%  
Current assets Rs m24,1677,523 321.2%   
Current liabilities Rs m9,5442,253 423.7%   
Net working cap to sales %74.347.7 155.6%  
Current ratio x2.53.3 75.8%  
Inventory Days Days5552 105.6%  
Debtors Days Days2941 70.8%  
Net fixed assets Rs m9,5141,240 767.4%   
Share capital Rs m458166 275.6%   
"Free" reserves Rs m26,3757,167 368.0%   
Net worth Rs m26,8327,333 365.9%   
Long term debt Rs m250-   
Total assets Rs m36,9009,912 372.3%  
Interest coverage x1,305.5NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.51.1 47.9%   
Return on assets %9.89.5 103.1%  
Return on equity %13.412.8 104.8%  
Return on capital %20.420.8 98.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m221,015 2.2%   
Fx outflow Rs m1,4893,043 48.9%   
Net fx Rs m-1,466-2,028 72.3%   
From Operations Rs m3,318537 618.3%  
From Investments Rs m-2,383-476 500.3%  
From Financial Activity Rs m-1,104-220 502.0%  
Net Cashflow Rs m-169-160 105.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.8 123.4%  
Indian inst/Mut Fund % 7.5 18.2 41.2%  
FIIs % 4.9 1.0 490.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 29.1 81.4%  
Shareholders   85,207 28,591 298.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster


Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Feb 22, 2019 (Close)